Sproutly Canada Past Earnings Performance
Past criteria checks 0/6
There is insufficient data on Sproutly Canada's performance over the last few years.
Key information
n/a
Earnings growth rate
n/a
EPS growth rate
| Pharmaceuticals Industry Growth | 23.1% |
| Revenue growth rate | n/a |
| Return on equity | n/a |
| Net Margin | n/a |
| Last Earnings Update | 30 Nov 2021 |
Recent past performance updates
Revenue & Expenses Breakdown
How Sproutly Canada makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Nov 21 | 1 | -14 | 1 | 0 |
| 31 Aug 21 | 0 | -13 | 1 | 0 |
| 31 May 21 | 1 | -15 | 2 | 0 |
| 28 Feb 21 | 0 | -16 | 2 | 0 |
| 30 Nov 20 | 0 | -59 | 4 | 0 |
| 31 Aug 20 | 1 | -59 | 5 | 0 |
| 31 May 20 | 1 | -61 | 6 | 0 |
| 29 Feb 20 | 1 | -62 | 8 | 0 |
| 30 Nov 19 | 1 | -12 | 10 | 0 |
| 31 Aug 19 | 0 | -12 | 10 | 0 |
| 31 May 19 | 0 | -14 | 9 | 0 |
| 28 Feb 19 | 0 | -13 | 8 | 0 |
| 30 Nov 18 | 0 | -10 | 5 | 0 |
| 31 Aug 18 | 0 | -9 | 3 | 0 |
| 31 May 18 | 0 | -4 | 3 | 0 |
Quality Earnings: Insufficient data to determine if SPR has high quality earnings.
Growing Profit Margin: Insufficient data to determine if SPR's profit margins have improved over the past year.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: Insufficient data to determine if SPR's year-on-year earnings growth rate was positive over the past 5 years.
Accelerating Growth: Insufficient data to compare SPR's past year earnings growth to its 5-year average.
Earnings vs Industry: Insufficient data to determine if SPR's earnings growth over the past year exceeded the Pharmaceuticals industry average.
Return on Equity
High ROE: SPR has a negative Return on Equity (0%), as it is currently unprofitable.